UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2022



Commission File Number: 001-37891

AC IMMUNE SA
(Exact name of registrant as specified in its charter)

EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
 
Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
 ☐
 
No

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
 ☐
 
No



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
AC IMMUNE SA
   
 
By:
/s/ Andrea Pfeifer
   
Name:
Andrea Pfeifer
   
Title:
Chief Executive Officer
       
     
By:
/s/ Joerg Hornstein
       
Name:
Joerg Hornstein
       
Title:
Chief Financial Officer
Date:
March 22, 2022
       

2

EXHIBIT INDEX

Exhibit Number
 
Description
 
Press Release dated March 22, 2022
 
2021 IFRS Consolidated Financial Statements
 
2021 Statutory Annual Report
 
2021 Compensation Report


3

AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more AC Immune Charts.
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more AC Immune Charts.